What Domes Pharma Groupe does

Dômes Pharma Groupe is a family-owned independent French pharmaceutical group, founded in 1947 and headquartered in Pont-du-Château, Auvergne, with 400 employees across 7 sites in France, the United Kingdom, Germany, Spain, the United States, and Canada. The group operates through vertically integrated subsidiaries covering the full drug value chain — research and development, GMP-certified manufacturing (Dômes Pharma Manufacturing, formerly Europhartech), and multi-channel marketing through field sales forces, pharmacy distribution, and e-commerce. The company is led across three generations by the Moulin family, with Dominique Moulin as President of the Management Board and Anne Moulin (third generation) leading North American expansion from Boston.

The company's commercial focus is on specialty therapeutic niches in companion animal health that are underserved by major pharmaceutical laboratories, including veterinary ophthalmology, poisoning management, epilepsy treatment, gastroenterology, and mobility (with the first stem cell-based veterinary medicine authorized in Europe). Core proprietary technologies include BioHAnce™ (patented crosslinked hyaluronic acid from the SentrX Animal Care acquisition) and Tasty Tech® palatable paste formulations. The portfolio spans 80+ specialty products across brands such as TVM/Dômes Pharma, Biocanina (10,000+ pharmacy clients), SentrX, Léro (human omega-3 supplements), and Aspivenin (first-aid medical device). The group also offers contract manufacturing services to third parties for human and veterinary pharmaceuticals.

Dômes Pharma generates revenue primarily through B2B sales of prescription and specialty pharmaceutical products to veterinary professionals and pharmacies, with 2022 consolidated turnover of €87M (~$95M) and product distribution across 20 countries. The go-to-market relies on dedicated field sales forces in each country, professional pharmacy distribution, a European distributor network, and a controlled e-commerce channel. Since 2015, the group has executed a deliberate international expansion strategy that has added subsidiaries in the UK, Germany, Spain, the US (2022), and Canada (2026), supplemented by the strategic acquisition of SentrX Animal Care in August 2023.

Name

Domes Pharma Groupe

Legal name

DÔMES PHARMA

Website

https://domespharma.com

Company type

Private

Founded year

1947

Operating status

Operating

Headcount range

251–500 employees

Short description

Dômes Pharma Groupe is a family-owned French pharmaceutical group founded in 1947, specializing in specialty veterinary therapeutics (ophthalmology, poisoning, epilepsy, mobility) and human health products. It serves veterinary professionals and pharmacies across 20 countries through vertically integrated R&D, manufacturing, and field sales.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

akta.pro secondary industries

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM), Online Veterinary Pharmacies & E-commerce Retailers (HLAMAIAF), Veterinary & Therapeutic Pet Diets (Prescription) (AFADAFAH)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Pharmaceutical manufacturing
• Ophthalmic solutions
• Nutraceutical supplements

Headquarters

HQ city

Pont-du-château

HQ country

France

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: The company develops, manufactures and markets specialty pharmaceutical products for animal health. Revenue comes from selling veterinary medicines, care products, and health supplements through direct sales forces and distribution networks.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Dômes Pharma Groupe develops, manufactures and markets specialty pharmaceutical products for animal and human health, with a portfolio of more than 80 specialty products concentrated in veterinary ophthalmology, poisoning management, epilepsy, gastroenterology, mobility, behavioral and senior animal care. The group operates a vertically integrated value chain spanning R&D, GMP-certified manufacturing (Dômes Pharma Manufacturing) and professional sales channels to veterinarians and pharmacies across Europe, the United States and Canada, complemented by the Aspivenin first-aid medical device and Léro human dietary supplements.

Product overview

Dômes Pharma Groupe is a family-owned independent pharmaceutical group with over 70 years of history, operating through vertically integrated subsidiaries covering the entire drug value chain from R&D to manufacturing and marketing. The portfolio centers on specialty therapeutic areas in animal health (ophthalmology, poisoning management, epilepsy, mobility) through its main TVM/Dômes Pharma brand and acquired SentrX Animal Care with its proprietary BioHAnce technology. Additional brands include Biocanina for veterinary products, Léro for human dietary supplements, and Aspivenin for first-aid devices. The group also operates Dômes Pharma Manufacturing as a GMP-certified contract manufacturing organization producing pharmaceutical products in solid oral and liquid forms for human and veterinary markets.

Differentiator

Problem solved

Functional benefit

Brands

• TVM / Dômes Pharma: Veterinary pharmaceutical brand specializing in ophthalmology, neurology, toxicology, and other therapeutic areas. Formerly TVM, now consolidated under Dômes Pharma brand. Offers 80+ specialty products for companion animals.
• Biocanina
• SentrX
• Léro
• Aspivenin
• Tasty Tech

Products and services

• Dômes Pharma (formerly TVM) Veterinary Specialty Products Main brand of the group covering 80+ specialty therapeutic products for companion animals across ophthalmology, neurology, toxicology (poisoning management), epilepsy, gastroenterology, behavior, mobility and senior animal care. Marketed to veterinarians through dedicated field sales delegates and to pharmacies through dedicated pharmacy sales forces.
• SentrX Animal Care BioHAnce Veterinary Ophthalmology Products US-based veterinary ophthalmology product line based on the proprietary BioHAnce™ crosslinked hyaluronic acid technology for ocular surface healing, lubrication and wound care in companion animals. Includes products such as Oculenis, Ocunovis and Eye Lub Pro.
• Biocanina Animal Health Brand Historical and iconic French animal health brand (founded 1963) offering a wide range of prescription and non-prescription veterinary medications, hygiene products and care products, distributed to more than 10,000 pharmacy clients in France.
• Léro Human Dietary Supplements Human health brand offering omega-3 dietary supplements from marine origin, supporting a holistic health approach combining healthy eating, regular physical activity and alternative wellness solutions.
• Aspivenin First-Aid Suction Pump First-aid pump medical device (founded 1983, Prix Lépine winner) for relieving pain from insect bites and stings or venomous animal bites. Market leader in France and distributed in 30 countries internationally.
• Dômes Pharma Manufacturing (Contract Manufacturing / CMO) GMP-certified contract manufacturing organization based in Auvergne, France, producing small to medium series of pharmaceutical products in solid oral (tablets, capsules, powders, Tasty Tech palatable pastes) and non-sterile liquid forms for human and veterinary pharmaceutical companies.

Quantifiable outcome

• 80+ specialty products across multiple therapeutic niches
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered major, core and minor.

• International Society of Veterinary Ophthalmology (ISVO)majorGTM or Marketing Partner · 26 January 2026Partnership through 'Dômes Pharma – ISVO Travel Scholarship' program to support training of young veterinarians in ophthalmology. Dômes Pharma funds three scholarships of $2,500 each in 2026.
• American College of Veterinary Ophthalmologists (ACVO)majorGTM or Marketing Partner · 26 January 2026Complementary partnership providing one-year free subscription to Veterinary Ophthalmology journal for ISVO Travel Scholarship recipients.
• SentrX Animal Care, Inc.coreStrategic or Co-development Partner · 16 August 2023Acquisition of US-based SentrX Animal Care (Salt Lake City, Utah) to strengthen global leadership in veterinary ophthalmology and create a launching pad for therapeutic products in North America. SentrX brings BioHAnce™ technology and 2,000 m2 manufacturing facility.
• EquicordminorStrategic or Co-development Partner · 22 June 2022Exclusive partnership announced June 2022 for product development and commercialization.

Scale indicators6 records

Recent moves12 records

Expansion highlights6 records

Broad incumbents

• Zoetis: Global leader in animal health pharmaceuticals, vaccines, diagnostics, and medicated feed. Broad incumbent whose companion animal portfolio overlaps with Dômes' specialty therapeutic areas; relevant as a competitive benchmark and potential acquirer of niche specialty assets.
• Elanco Animal Health: Global pure-play animal health company offering companion animal and livestock pharmaceuticals, vaccines, and parasiticides. Broad incumbent whose extensive portfolio across multiple therapeutic categories competes with Dômes across many of its specialty niches.
• Boehringer Ingelheim Animal Health: One of the largest global animal health businesses, offering pharmaceuticals, vaccines, and parasite control for companion and production animals. Broad incumbent with overlapping veterinary pharma products; Ana Morcate, Dômes' Spain Country Manager, previously led its Spanish animal health business.

Direct peers

• Ceva Santé Animale: French veterinary pharmaceutical group with a strong specialty pharma portfolio (companion animal vaccines, cardiology, dermatology, behavior). Comparable independent French origin, specialty positioning, and international expansion playbook in companion animal health.
• Dechra Pharmaceuticals: UK-headquartered specialty veterinary pharmaceuticals company (acquired by EQT) focused on niche therapeutic areas including ophthalmology, endocrinology, dermatology, and pain management. Highly comparable specialty-pharma strategy and product overlap in ophthalmology.
• Virbac: French independent animal health company focused on companion and food-producing animal pharmaceuticals, biologics, and diagnostics. Closest direct peer given shared French origins, independent ownership heritage, specialty pharma positioning, and overlapping therapeutic areas including dermatology and specialty therapeutics.
• Vetoquinol: French-listed veterinary pharmaceutical company specializing in companion animal therapeutics across multiple therapeutic niches with international subsidiaries. Directly comparable business model, customer base (veterinary professionals), and product portfolio breadth to Dômes Pharma.
• Norbrook Laboratories: UK-headquartered veterinary pharmaceutical manufacturer offering anti-infectives, anti-inflammatories, parasiticides, and specialty products to global markets. Comparable in being a privately held, multi-site veterinary pharma manufacturer with international distribution.

Emerging players

• Phibro Animal Health: Animal health and nutrition company focused on livestock and companion animal pharmaceuticals, vaccines, and mineral nutrition. Smaller public peer in the animal-health pharma space whose specialty product strategy partially overlaps Dômes' therapeutic-niche approach.

Others

• TVM (historical): Former name of Dômes Pharma's flagship French veterinary laboratory (rebranded to Dômes Pharma France in 2023). Listed only to clarify that historical TVM competitive landscape data is now captured under the Dômes Pharma entity.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/fondation-domes-pharma
• Xx.com/DomesPharma

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Domes Pharma Groupe